Critical role of tissue kallikrein in vessel formation and maturation: Implications for therapeutic revascularization

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 5, 2009, Pages 657-664

  Stone, Oliver A ^a   Richer, Christine ^b   Emanueli, Costanza ^a   Van Weel, Vincent ^c,d   Quax, Paul H A ^c,d   Katare, Rajesh ^a   Kraenkel, Nicolle ^a   Campagnolo, Paola ^a   Barcelos, Luciola S ^a   Siragusa, Mauro ^a   Sala Newby, Graciela B ^a   Baldessari, Danila ^e   Mione, Marina ^e   Vincent, Marie P ^b   Benest, Andrew V ^a   Al Haj Zen, Ayman ^a   Gonzalez, Julien ^f   Bates, David O ^a   Alhenc Gelas, Francois ^b   Madeddu, Paolo ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c TNO   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^f INSERM   (France)

Author keywords

Angiogenesis; Gene mutations; Gene therapy; Metalloproteinases; Tissue kallikrein

Indexed keywords

GELATINASE B; TISSUE KALLIKREIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; GENE OVEREXPRESSION; GENE TRANSFER; KNOCKOUT MOUSE; LIMB ISCHEMIA; MALE; MONONUCLEAR CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN VARIANT; RAT; REVASCULARIZATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WILD TYPE; ZEBRA FISH; ANIMAL; HINDLIMB; HUMAN; ISCHEMIA; KALLIKREIN KININ SYSTEM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; SPLANCHNIC BLOOD FLOW; VASCULARIZATION; WOUND HEALING;

ANIMALS; HINDLIMB; HUMANS; ISCHEMIA; KALLIKREIN-KININ SYSTEM; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; SPLANCHNIC CIRCULATION; TISSUE KALLIKREINS; WOUND HEALING; ZEBRAFISH;

EID: 65549102213     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.182139     Document Type: Article

References (24)

1. Pepper MS. Role of the matrix metalloproteinase and plasminogen acti-vator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol. 2001;21:1104-1117.
2. Milia AF, Salis MB, Stacca T, Pinna A, Madeddu P, Trevisani M, Geppetti P, Emanueli C. Protease-activated receptor-2 stimulates angio-genesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia. Circ Res. 2002;91:346-352.
3. Emanueli C, Salis MB, Pinna A, Stacca T, Milia AF, Spano A, Chao J, Chao L, Sciola L, Madeddu P. Prevention of diabetes-induced microan-giopathy by human tissue kallikrein gene transfer. Circulation. 2002;106: 993-999.
4. Emanueli C, Salis MB, Van Linthout S, Meloni M, Desortes E, Silvestre JS, Clergue M, Figueroa CD, Gadau S, Condorelli G, Madeddu P. Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer. Circulation. 2004;110:1638-1644.
5. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 1992;44:1-80.
6. Yao YY, Yin H, Shen B, Smith RS Jr, Liu Y, Gao L, Chao L, Chao J. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3{beta} pathway. Cardiovasc Res. 2008;80:354-364.
7. Emanueli C, Bonaria Salis M, Stacca T, Pintus G, Kirchmair R, Isner JM, Pinna A, Gaspa L, Regoli D, Cayla C, Pesquero JB, Bader M, Madeddu P. Targeting kinin B(1) receptor for therapeutic neovascularization. Circulation. 2002;105:360-366.
8. Madeddu P, Emanueli C, El-Dahr S. Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling. Nat Clin Pract Nephrol. 2007;3:208-221.
9. Meneton P, Bloch-Faure M, Hagege AA, Ruetten H, Huang W, Bergaya S, Ceiler D, Gehring D, Martins I, Salmon G, Boulanger CM, Nussberger J, Crozatier B, Gasc JM, Heudes D, Bruneval P, Doetschman T, Menard J, Alhenc-Gelas F. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc Natl Acad Sci U S A. 2001;98:2634-2639.
10. Slim R, Torremocha F, Moreau T, Pizard A, Hunt SC, Vuagnat A, Williams GH, Gauthier F, Jeunemaitre X, Alhenc-Gelas F. Loss-of-function polymorphism of the human kallikrein gene with reduced urinary kallikrein activity. J Am Soc Nephrol. 2002;13:968-976.
11. Azizi M, Boutouyrie P, Bissery A, Agharazii M, Verbeke F, Stern N, Bura-Riviere A, Laurent S, Alhenc-Gelas F, Jeunemaitre X. Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest. 2005;115:780-787.
12. George SJ, Johnson JL, Angelini GD, Newby AC, Baker AH. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. Hum Gene Ther. 1998;9:867-877.
13. Bergaya S, Hilgers RH, Meneton P, Dong Y, Bloch-Faure M, Inagami T, Alhenc-Gelas F, Levy BI, Boulanger CM. Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors. Circ Res. 2004;94:1623-1629.
14. Hilgers RH, Bergaya S, Schiffers PM, Meneton P, Boulanger CM, Henrion D, Levy BI, De Mey JG. Uterine artery structural and functional changes during pregnancy in tissue kallikrein-deficient mice. Arterioscler Thromb Vasc Biol. 2003;23:1826-1832.
15. Cheshier SH, Morrison SJ, Liao X, Weissman IL. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci U S A. 1999;96:3120-3125.
16. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702-712.
17. Bromee T, Kukkonen JP, Andersson P, Conlon JM, Larhammar D. Pharmacological characterization of ligand-receptor interactions at the zebrafish bradykinin receptor. Br J Pharmacol. 2005;144:11-16.
18. Lawson ND, Weinstein BM. Arteries and veins: making a difference with zebrafish. Nat Rev Genet. 2002;3:674-682.
19. van Weel V, de Vries M, Voshol PJ, Verloop RE, Eilers PH, van Hinsbergh VW, van Bockel JH, Quax PH. Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice. Arterioscler Thromb Vasc Biol. 2006;26:1383-1390.
20. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625- 637.
21. Krankel N, Katare RG, Siragusa M, Barcelos LS, Campagnolo P, Mangialardi G, Fortunato O, Spinetti G, Tran N, Zacharowski K, Wojakowski W, Mroz I, Herman A, Manning Fox JE, MacDonald PE, Schanstra JP, Bascands JL, Ascione R, Angelini G, Emanueli C, Madeddu P. Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res. 2008;103:1335-1343.
22. Chao J, Yin H, Gao L, Hagiwara M, Shen B, Yang ZR, Chao L. Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation. Hypertension. 2008;52:715-720.
23. Wang WY, Whittles CE, Harper SJ, Bates DO. An adenovirus-mediated gene-transfer model of angiogenesis in rat mesentery. Microcirculation. 2004;11:361-375.
24. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res. 2005;97:512-523.